Frank Jaksch - Chromadex Corp Co-Founder, CEO and President and Director
| CDXC Stock | USD 3.93 0.08 2.08% |
CEO
Mr. Frank L. Jaksch is no longer Chief Executive Officer, Director of ChromaDex Corporationrationration., effective June 22, 2018. He is a cofounder of the Company and has served as a member of Board since February 2000. Mr. Jaksch served as Chairman of the Board from May 2010 to October 2011 and was its CoChairman from February 2000 to May 2010. Mr. Jaksch currently serves as our Chief Executive Officer. Mr. Jaksch oversees research, strategy and operations for the Company with a focus on scientific and novel products for pharmaceutical and nutraceutical markets. From 1993 to 1999, Mr. Jaksch served as International Subsidiaries Manager of Phenomenex, a life science supply company where he managed the international subsidiary and international business development divisions
| Age | 56 |
| Address | 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024 |
| Phone | 310 388 6706 |
| Web | https://www.chromadex.com |
Chromadex Corp Management Efficiency
The company has return on total asset (ROA) of (0.0642) % which means that it has lost $0.0642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1729) %, meaning that it created substantial loss on money invested by shareholders. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of April 16, 2024, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.06. At present, Chromadex Corp's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 28.4 M.Similar Executives
| Found 8 records | CEO Age | ||
| Albert White | The Cooper Companies | 51 | |
| Christopher Simon | Haemonetics | 60 | |
| Paul Remmell | The Cooper Companies | 58 | |
| Michael Farrell | ResMed Inc | 48 | |
| Albert III | The Cooper Companies | 54 | |
| Gary Guthart | Intuitive Surgical | 58 | |
| Robert Weiss | The Cooper Companies | 74 | |
| Eric Green | West Pharmaceutical Services | 54 | |
Management Performance
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.0642 |
Chromadex Corp Leadership Team
Elected by the shareholders, the Chromadex Corp's board of directors comprises two types of representatives: Chromadex Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chromadex. The board's role is to monitor Chromadex Corp's management team and ensure that shareholders' interests are well served. Chromadex Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chromadex Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kendall Knysch, Head Partnerships | ||
| Troy Rhonemus, COO | ||
| Mark Friedman, General Counsel and Corporate Secretary | ||
| Brianna Gerber, Senior Director of FP&A, IR Contact Officer | ||
| Thomas Varvaro, CFO, Principal Accounting Officer and Secretary | ||
| Frank Jaksch, Co-Founder, CEO and President and Director | ||
| William Smithburg, Independent Director | ||
| Chu Yan, Managing Pacific | ||
| Jeffrey Baxter, Independent Director | ||
| Jason Campbell, Senior Development | ||
| Reid Dabney, Independent Director | ||
| Andrew Johnson, Director of Investor Relations, IR Contact Officer | ||
| Lisa Bratkovich, Chief Marketing Officer | ||
| Hugh Dunkerley, Independent Director | ||
| Tony Lau, Director | ||
| Heather Blarcom, Senior Secretary | ||
| Stephen Block, Independent Director | ||
| Stephen Allen, Chairman of the Board | ||
| Andrew Shao, Senior Affairs | ||
| Steven Rubin, Director | ||
| Jeff Baxter, Independent Director | ||
| Kevin Farr, CFO | ||
| Matthew Roberts, Senior Vice President - Innovation, Chief Scientific Officer | ||
| Wendy Yu, Director | ||
| Robert Fried, Independent Director | ||
| David Kroes, Senior Matters | ||
| Alex Worsham, Vice Communications | ||
| Tom Shumaker, Managing Advisors | ||
| Fadi Karam, Chief Officer | ||
| Kurt Gustafson, Director |
Chromadex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chromadex Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.0642 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 266.69 M | ||||
| Shares Outstanding | 75.31 M | ||||
| Shares Owned By Insiders | 41.18 % | ||||
| Shares Owned By Institutions | 16.10 % | ||||
| Number Of Shares Shorted | 1.32 M | ||||
| Price To Earning | (19.51) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chromadex Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chromadex Corp's short interest history, or implied volatility extrapolated from Chromadex Corp options trading.
Pair Trading with Chromadex Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chromadex Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chromadex Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with Chromadex Stock
| 0.69 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.9 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Chromadex Stock
| 0.74 | BNR | Burning Rock BiotechLtd Financial Report 4th of June 2024 | PairCorr |
| 0.73 | JNJ | Johnson Johnson Earnings Call Today | PairCorr |
| 0.71 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.68 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chromadex Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chromadex Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chromadex Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chromadex Corp to buy it.
The correlation of Chromadex Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chromadex Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chromadex Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chromadex Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Chromadex Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.07) | Revenue Per Share 1.114 | Quarterly Revenue Growth 0.01 | Return On Assets (0.06) | Return On Equity (0.17) |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.